The Management of Cardiovascular Risk through Epigenetic Biomarkers - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue BioMed Research International Année : 2017

The Management of Cardiovascular Risk through Epigenetic Biomarkers

(1) , (2) , (2)
1
2

Résumé

Epigenetic sciences study heritable changes in gene expression not related to changes in the genomic DNA sequence. The most important epigeneticmechanisms are DNA methylation, posttranslational histone modification, and gene regulation by noncoding RNAs, such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs). Cardiovascular diseases (CVD) are responsible for at least one-third of premature deaths worldwide and represent a heavy burden of healthcare expenditure. We will discuss in this review the most recent findings dealing with epigenetic alterations linked to cardiovascular physiopathology in patients. A particular focus will be put on the way these changes can be translated in the clinic, to develop innovative and groundbreaking biomarkers in CVD field.

Dates et versions

hal-03584412 , version 1 (22-02-2022)

Identifiants

Citer

Laurent Metzinger, Stefano De Franciscis, Raffaele Serra. The Management of Cardiovascular Risk through Epigenetic Biomarkers. BioMed Research International , 2017, 2017, ⟨10.1155/2017/9158572⟩. ⟨hal-03584412⟩
17 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More